Cases & Deals

Sunesis Pharmaceuticals successfully prosecutes U.S. patent for vosaroxin

Clients Sunesis Pharmaceuticals, Inc.

On behalf of Sunesis Pharmaceuticals, Inc., Jones Day successfully prosecuted a U.S. patent application for vosaroxin which is used in the treatment of leukemia. The patent issued as United States Patent No. 7,989,468.